Insiders Updates
Rigel Pharmaceuticals (RIGL) gets rating Resumed from Piper Sandler
Rigel Pharmaceuticals’s recently made public that its EVP & Chief Financial Officer Schorno Dean L unloaded Company’s shares for reported
Menu
Rigel Pharmaceuticals’s recently made public that its EVP & Chief Financial Officer Schorno Dean L unloaded Company’s shares for reported
Rigel Pharmaceuticals Inc. (RIGL), a biotechnology company specializing to manufacture and commercialize novel molecule drugs, soared 12.14% at $3.46 in